Source link : https://newshealth.biz/health-news/myeloma-combo-with-unprecedented-effect-wins-fda-approval/
(MedPage Today) — A promising combination for multiple myeloma received FDA approval as a second-line therapy. The approval of teclistamab (Tecvayli) plus daratumumab hyaluronidase (Darzalex Faspro) stipulates use in patients who have received… Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/120201 Author : Publish date : 2026-03-06 18:43:00 Copyright for syndicated content belongs to the linked Source.
The post Myeloma Combo With ‘Unprecedented’ Effect Wins FDA Approval first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-06 18:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8